首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Bioorganic & medicinal chemistry

缩写:BIOORGAN MED CHEM

ISSN:0968-0896

e-ISSN:1464-3391

IF/分区:3.5/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引11373
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Jinqiu Li,Jiayi Zhu,Xinhao Wei et al. Jinqiu Li et al.
The identification of novel candidate molecules with breakthrough potential is critical for advancing breast cancer therapy. Lasioglossum-III (LL-III), a linear peptide isolated from wild bee venom, has emerged as a promising lead compound ...
Shuang Hao,Jing-Han Yan,Rui Wang et al. Shuang Hao et al.
Based on the structure of the existing drug afatinib, this study employed the heterocyclic-containing tail modification strategy to design and synthesize a series of novel pyrimidine derivatives, aiming to develop highly selective and low-t...
Narufumi Kitamura,Keiji Kajiwara,Shoichi Yamamoto et al. Narufumi Kitamura et al.
Intracellular oxygen concentration is a pivotal indicator of cellular metabolic and functional states that may be influenced by pathologic conditions, including hypoxia in solid tumors and hyperglycemia. Currently, methods for quantifying c...
Md Ayub Ali,Dan Feng,Staci L Haney et al. Md Ayub Ali et al.
Geranylgeranyl diphosphate synthase (GGDPS), the enzyme responsible for producing the isoprenoid substrate used in protein geranylgeranylation reactions, represents a novel therapeutic target in cancer, including malignancies such as multip...
Mengyao Peng,Mengni He,Jie Wang et al. Mengyao Peng et al.
Cisplatin is a widely used chemotherapeutic agent, but its clinical application is limited by toxic side effects and an "immunological paradox": while chemotherapy kills tumor cells, it also induces upregulation of PD-L1, leading to immune ...
Xue Feng,Yuanzhen Dong,Chen Guo et al. Xue Feng et al.
Trofinetide is the only drug approved worldwide for the treatment of Rett syndrome, a rare pediatric disease. However, its extremely short half-life, large oral dose, high incidence of gastrointestinal adverse reactions, and consequently hi...
Hong Lei,Xiaocui Feng,Runling Yang et al. Hong Lei et al.
Renal fibrosis, as the ultimate common pathway for the development of various kidney diseases, is characterized by abnormal accumulation of extracellular matrix (ECM) and destruction of renal structure, resulting in progressive, irreversibl...
Yunqing Gao,Zhenghao Sun,Qiumei Wei et al. Yunqing Gao et al.
Developing high-affinity ligands targeting TDP-43 amyloid species is a potential therapeutic approach for amyotrophic lateral sclerosis (ALS). Here, we propose an integrated computational simulation strategy, which integrates multiple virtu...
Yilong Zhuang,Yaowen Cui,Tingting Chen et al. Yilong Zhuang et al.
Radiation-induced skin injury (RSI) is a common and debilitating complication of radiotherapy, significantly impairing patients' quality of life. High-Mobility Group Box 1 (HMGB1), a key damage-associated molecular pattern (DAMP) protein, p...
Yueyang Cao,Jiayi Luo,Yong Yang et al. Yueyang Cao et al.
Human carboxylesterase 2A (hCES2A) is a key mediator of drug metabolism and chemotherapeutic side effects, necessitating potent and selective inhibitors. Herein, 42 novel steroid derivatives were rationally designed via hCES2A homology mode...